DrugPatentWatch

What DrugPatentWatch does

DrugPatentWatch, operated by thinkBiotech LLC and founded in 2002 by Yali Friedman, is a subscription-based SaaS biopharmaceutical intelligence platform that aggregates primary-source patent, regulatory, litigation, pricing, and market data across 134 countries and refreshes every drug profile daily. Its core offering combines a Global Drug Patents Database (covering active and expired patents, Orange Book listings, Paragraph IV challenges, ANDA filings, and regulatory exclusivities), a Patent Litigation Intelligence module (US District Court and PTAB proceedings), Sales Analytics, and an AI Research Assistant branded as the Deep Research Engine that synthesizes answers across the dataset with full source citations. Supporting modules extend coverage to biologics and biosimilars, investigational drugs in Phase I-III trials, US drug prices, top drug sales, and excipients, giving customers a single platform to forecast generic entry, monitor patent cliffs, support Paragraph IV and BPCIA strategies, and run M&A and investment due diligence.

The platform sells on a three-tier subscription: Starter ($1,000/month or $8,000/year) for low-volume users with basic searches; Professional ($3,000/month or $24,000/year) with unlimited searches, data export, custom alerts, and Deep Research Engine access; and Enterprise (custom multi-year contracts) with no usage logging, unlimited enterprise users, a dedicated account director, executive training, and bespoke intelligence reports. A $299 one-week trial and $499 one-month all-access promotional offer drive self-serve conversion, while enterprise sales handles large accounts. Go-to-market combines direct website sales, content marketing through an extensive 126+-page blog, SEO, and earned media citations (CNN, NEJM, Nature, Reuters, Bloomberg, FiercePharma). The customer base spans innovator pharma and biotech, generic manufacturers, biosimilar developers, law firms, institutional investors, consultants, and academic/government institutions across 76+ countries, with named enterprise users including Merck, Teva, Express Scripts, Colorcon, Harvard Business School, and the US Army. The business is bootstrapped, founder-owned, and reportedly operates with 1-10 employees under a single LLC.

Name

DrugPatentWatch

Legal name

thinkBiotech LLC

Website

https://drugpatentwatch.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

1–10 employees

Short description

DrugPatentWatch is a SaaS biopharmaceutical intelligence platform, founded in 2002, that aggregates primary-source patent, regulatory, litigation, pricing, and market data across 134 countries for pharmaceutical and biotech companies, generic manufacturers, law firms, investors, and government clients.

Ownership category

akta.pro rank

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Subscription SaaS Platform: Tiered subscription model providing access to pharmaceutical patent intelligence database, litigation tracking, and AI-powered research tools. Revenue generated through monthly/annual subscription fees with tiered pricing based on access level and feature set.
2. Professional Services: Enterprise solutions including bespoke intelligence reports, executive training programs, and dedicated account management for large organizations requiring custom implementations.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

DrugPatentWatch is a SaaS biopharmaceutical intelligence platform that aggregates primary-source patent data, FDA regulatory filings (Orange Book, ANDA), litigation records, and prescription sales data across 134 countries. Delivered through tiered subscriptions with an AI-powered Deep Research Engine, the platform serves pharmaceutical, biotech, generic, legal, and investment professionals seeking actionable drug patent and market intelligence.

Product overview

DrugPatentWatch is a unified biopharmaceutical intelligence platform that combines multiple data modules including patent intelligence, FDA regulatory data, litigation tracking, market forecasting, and competitive analysis. The platform is built around a core infrastructure spanning pharmaceutical drugs (patents, regulatory protections, ANDAs, Paragraph IV challenges), biologics (patents, biosimilar tracking), litigation (US District Court and PTAB proceedings), drug pricing, sales analytics, and an AI-powered Deep Research Engine. Available through three subscription tiers (Starter, Professional, Enterprise) ranging from basic searches to unlimited access with AI research capabilities and data export.

Differentiator

Problem solved

Functional benefit

Brands

• DrugChatter: A platform focused on monitoring AI-driven and digital conversations about drugs and healthcare.

Products and services

• Patent Litigation Intelligence (Litigation Tracker)

Quantifiable outcome

• A branded drug generating $1 billion annually in revenue produces roughly $2.7 million per day, making accurate patent expiry timing critical for investment and business decisions.
• +1 more outcomes

Named customers6 records

Segments7 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

One partnership is on record.

• DrugChatterminorOthersDrugChatter is a related platform also founded by Yali Friedman (founder of DrugPatentWatch) focused on monitoring AI-driven and digital conversations about drugs and healthcare. While not a formal commercial partnership, it represents the founder's broader ecosystem of pharmaceutical intelligence tools.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Clarivate (Cortellis): Clarivate's Cortellis platform provides competitive intelligence, patent data, and regulatory insights for the pharmaceutical industry. It is a direct competitor in pharma IP and competitive intelligence, serving similar innovator and generic pharmaceutical customers with overlapping patent and exclusivity analytics.
• Norstella (Evaluate Pharma): Evaluate Pharma, now part of Norstella, provides pharmaceutical commercial intelligence including drug sales forecasts, pipeline analysis, and patent/exclusivity tracking. It is a direct competitor in pharma competitive intelligence and LOE analytics for the same buyer base.
• PatSnap: PatSnap is an AI-powered patent and innovation intelligence platform covering global patent data, R&D analytics, and competitive intelligence. It overlaps with DrugPatentWatch in pharma patent analytics and serves similar legal, R&D, and investment customers with comparable AI-driven search capabilities.
• PharmaCircle: PharmaCircle is a business intelligence platform providing pipeline, product, patent, and company information for the pharmaceutical industry. It is a direct competitor focused specifically on pharma with subscription tiers analogous to DrugPatentWatch.
• Questel (Orbit Intelligence): Questel's Orbit Intelligence provides global patent search, analytics, and IP intelligence including pharmaceutical patent landscapes. It competes directly in patent analytics with comparable patent family and LOE tracking capabilities.

Broad incumbents

• IQVIA: IQVIA is a global leader in healthcare data, analytics, and clinical research, offering market intelligence, commercial analytics, and real-world evidence to pharmaceutical companies. It competes with DrugPatentWatch in pharma market intelligence but as part of a much broader services portfolio.
• GlobalData Pharmaceutical: GlobalData provides industry intelligence including pharmaceutical market forecasts, drug pipeline analysis, and patent insights. It competes as a broader incumbent offering pharma intelligence that overlaps with DrugPatentWatch's market and competitive analytics.
• LexisNexis PatentSight: LexisNexis PatentSight provides patent analytics and portfolio valuation across industries including pharmaceuticals. It competes in patent quality, valuation, and landscape analytics with enterprise customers overlapping with DrugPatentWatch's buyer base.

Emerging players

• DrugBank: DrugBank is a pharmaceutical knowledge base providing detailed drug, chemical, and pharmacological data. It overlaps with DrugPatentWatch in pharma data infrastructure and serves similar research and analytics customers, though with stronger chemical/pharmacology depth than patent depth.
• Anaqua (AcclaimIP): Anaqua's AcclaimIP platform provides patent analytics, search, and IP management for law firms and corporate IP teams. It competes in pharmaceutical patent analytics with comparable search and litigation tracking capabilities, particularly for IP-focused legal customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/drugpatentwatch
• LinkedInlinkedin.com/company/drugpatentwatch

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DrugPatentWatch